Codexis Inc (NASDAQ: CDXS) on Tuesday, soared 7.39% from the previous trading day, before settling in for the closing price of $2.84. Within the past 52 weeks, CDXS’s price has moved between $1.90 and $6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -33.31% over the past five years. The company achieved an average annual earnings per share of 22.15%. With a float of $80.17 million, this company’s outstanding shares have now reached $82.84 million.
Let’s look at the performance matrix of the company that is accounted for 188 employees. In terms of profitability, gross margin is 69.08%, operating margin of -134.4%, and the pretax margin is -149.4%.
Codexis Inc (CDXS) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Codexis Inc is 3.23%, while institutional ownership is 82.81%. The most recent insider transaction that took place on Jul 18 ’25, was worth 282,000. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $2.82, taking the stock ownership to the 12,450,000 shares. Before that another transaction happened on Jun 27 ’25, when Company’s 10% Owner bought 100,000 for $2.39, making the entire transaction worth $239,000. This insider now owns 12,350,000 shares in total.
Codexis Inc (CDXS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.30% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Codexis Inc (CDXS) is currently performing well based on its current performance indicators. A quick ratio of 3.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Codexis Inc (NASDAQ: CDXS) saw its 5-day average volume 0.62 million, a negative change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 50.57%.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 51.11%, which indicates a significant decrease from 85.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.53, while its 200-day Moving Average is $3.41. Nevertheless, the first resistance level for the watch stands at $3.18 in the near term. At $3.32, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.49. If the price goes on to break the first support level at $2.87, it is likely to go to the next support level at $2.70. Assuming the price breaks the second support level, the third support level stands at $2.56.
Codexis Inc (NASDAQ: CDXS) Key Stats
Market capitalization of the company is 252.68 million based on 82,845K outstanding shares. Right now, sales total 59,350 K and income totals -65,280 K. The company made 7,540 K in profit during its latest quarter, and -20,690 K in sales during its previous quarter.
